A Comparison of Chemotherapy Used with and without Apatinib for Patients with Ovarian Carcinoma Who Progressed after Standard Regimens: A Systematic Review and Meta-Analysis

<div>Disease control rate of chemotherapy plus apatinib in comparison with chemotherapy alone in the patients with ovarian carcinoma.</div>

Evidence-Based Complementary and Alternative Medicine

fig4

Figure 4

Figure 4: A Comparison of Chemotherapy Used with and without Apatinib for Patients with Ovarian Carcinoma Who Progressed after Standard Regimens: A Systematic Review and Meta-Analysis 

Figure 4 | A Comparison of Chemotherapy Used with and without Apatinib for Patients with Ovarian Carcinoma Who Progressed after Standard Regimens: A Systematic Review and Meta-Analysis 